OPI8 Antibody

What is ORP8/OSBPL8 and what specific cellular functions does it perform?

ORP8/OSBPL8 is a lipid transporter that mediates countertransport between the endoplasmic reticulum and plasma membrane. It specifically exchanges phosphatidylserine with phosphatidylinositol 4-phosphate (PI4P), delivering phosphatidylserine to the plasma membrane in exchange for PI4P, which is subsequently degraded by the SAC1/SACM1L phosphatase in the endoplasmic reticulum. The protein binds phosphatidylserine and PI4P in a mutually exclusive manner. Additionally, it demonstrates binding affinity for oxysterol, 25-hydroxycholesterol, and cholesterol .

This protein is known by several alternative names in scientific literature:

• KIAA1451

• ORP8

• OSBP10

• OSBPL8

• Oxysterol-binding protein-related protein 8

• OSBP-related protein 8

Understanding these functions provides crucial context for appropriate antibody selection and experimental design when studying lipid transport mechanisms.

What types of ORP8/OSBPL8 antibodies are commercially available and how should researchers select the appropriate one?

Currently, several validated antibodies against ORP8/OSBPL8 are available, with rabbit polyclonal antibodies being the most commonly documented. These antibodies are typically generated using recombinant fragment proteins within Human OSBPL8 as immunogens .

When selecting an ORP8/OSBPL8 antibody, researchers should consider:

The rabbit polyclonal ORP8 antibodies currently available have been validated for Western Blotting (WB) and Immunocytochemistry/Immunofluorescence (ICC/IF) with human samples . This validation information should guide application selection during experimental design.

What established experimental applications are most effective for ORP8/OSBPL8 antibodies?

ORP8/OSBPL8 antibodies have been validated for multiple experimental applications, each providing different insights into protein expression, localization, and function.

For ORP8/OSBPL8 specifically, researchers should note that its localization between the endoplasmic reticulum and plasma membrane may require optimized fixation and permeabilization protocols to preserve both membranous structures when performing ICC/IF .

What validation methods ensure reliable results with ORP8/OSBPL8 antibodies?

Following the International Working Group for Antibody Validation (IWGAV) recommendations, researchers should validate ORP8/OSBPL8 antibodies using multiple complementary approaches:

• Orthogonal validation: Compare antibody-based measurements with independent, antibody-independent methods (e.g., mass spectrometry, mRNA expression) .

• Genetic validation: Confirm absence of signal in knockout/knockdown models of ORP8/OSBPL8 .

• Independent antibody validation: Use multiple antibodies targeting different epitopes of ORP8/OSBPL8 to confirm consistent results .

• Tagged-protein expression: Express ORP8/OSBPL8 with an affinity tag and validate antibody detection against the known tag .

• High-throughput functional screening: For advanced validation, consider functional screening approaches that assess antibody performance across multiple conditions .

Implementation of at least three validation methods is recommended to establish antibody reliability for critical research applications.

How does antibody validation methodology for ORP8/OSBPL8 differ from standard validation protocols?

Due to ORP8/OSBPL8's lipid-binding functions and membrane association, standard validation protocols require specific modifications:

• Membrane protein extraction considerations: Standard lysis buffers may inadequately solubilize ORP8/OSBPL8. Protocols should be optimized with appropriate detergents (e.g., CHAPS, NP-40, or Triton X-100) to efficiently extract membrane-associated proteins.

• Lipid-binding interference assessment: Verify whether the presence of lipid ligands (phosphatidylserine, PI4P, cholesterol) affects antibody binding to ensure experimental conditions won't interfere with detection.

• Subcellular fractionation validation: Confirm antibody specificity in both endoplasmic reticulum and plasma membrane fractions, as ORP8/OSBPL8 distributes between these compartments .

• Cross-reactivity testing: Test against related OSBP family members to ensure specificity within this structurally similar protein family.

These validation steps are particularly important when studying lipid transport dynamics, as they ensure that antibody binding remains consistent regardless of ORP8/OSBPL8's conformational changes during its transport cycle.

How can researchers optimize Western blot protocols for detecting ORP8/OSBPL8 in different cellular contexts?

Western blot optimization for ORP8/OSBPL8 detection requires attention to several technical parameters:

For tissues with lipid-rich environments (brain, adipose tissue), additional sample preparation steps may be necessary to remove interfering lipids before electrophoresis. This might include chloroform/methanol extraction followed by protein precipitation.

When analyzing ORP8/OSBPL8 expression across multiple cell types, standardization to appropriate loading controls is critical, as traditional housekeeping proteins may vary significantly between tissues with different lipid metabolism profiles.

What techniques can be employed to study ORP8/OSBPL8 interactions with binding partners and lipid substrates?

Investigating ORP8/OSBPL8 interactions requires specialized approaches due to its dual protein-protein and protein-lipid binding capabilities:

• Co-immunoprecipitation with lipid preservation:

  • Utilize mild detergents (0.5-1% NP-40 or digitonin)

  • Include phosphatase inhibitors to prevent PI4P degradation

  • Consider chemical crosslinking before lysis to capture transient interactions

• Proximity labeling in intact cells:

  • BioID or APEX2 fusion constructs with ORP8/OSBPL8

  • Allows identification of proximal proteins in native membrane environments

  • Particularly valuable for capturing dynamic interaction networks

• Lipidomic analysis of immunoprecipitated complexes:

  • Liquid chromatography-mass spectrometry to analyze co-precipitated lipids

  • Requires careful optimization to preserve lipid-protein associations

  • Controls must include antibody-only samples to account for non-specific lipid binding

• FRET/BRET-based interaction assays:

  • Enables real-time monitoring of interactions in living cells

  • Can detect conformational changes upon lipid binding

  • Requires careful construct design to maintain protein function

These methodologies enable comprehensive characterization of both stable and transient interactions that regulate ORP8/OSBPL8 function in lipid transport processes.

How can researchers employ ORP8/OSBPL8 antibodies to investigate its role in lipid transport mechanisms?

ORP8/OSBPL8 antibodies can be strategically employed to elucidate lipid transport mechanisms through several advanced approaches:

• Subcellular fractionation with immunoblotting:

  • Isolate membrane fractions (ER, PM, contact sites)

  • Quantify ORP8/OSBPL8 distribution across fractions

  • Monitor redistribution following lipid challenges or cellular perturbations

• Immunofluorescence co-localization studies:

  • Dual labeling with organelle markers and ORP8/OSBPL8

  • Super-resolution microscopy to visualize membrane contact sites

  • Live-cell imaging with complementary fluorescent lipid probes

• Immunoprecipitation coupled with lipid analysis:

  • Pull down ORP8/OSBPL8 under native conditions

  • Analyze bound lipids via mass spectrometry

  • Compare lipid profiles under various cellular conditions

• Antibody-mediated functional disruption:

  • Microinjection of antibodies targeting specific domains

  • Monitor effects on phosphatidylserine/PI4P distribution

  • Assess impact on downstream lipid-dependent processes

These approaches have revealed that ORP8/OSBPL8 specifically exchanges phosphatidylserine with PI4P at membrane contact sites, delivering phosphatidylserine to the plasma membrane while retrieving PI4P for degradation in the endoplasmic reticulum .

What strategies can resolve contradictory results when using different ORP8/OSBPL8 antibodies?

When faced with discrepant results using different ORP8/OSBPL8 antibodies, researchers should implement a systematic troubleshooting approach:

• Epitope mapping comparison:

  • Determine precise epitopes recognized by each antibody

  • Assess if post-translational modifications might affect epitope accessibility

  • Consider if protein conformation influences antibody access

• Cross-validation with orthogonal methods:

  • Implement antibody-independent detection methods

  • Use genetic approaches (CRISPR knockout/knockdown with rescue)

  • Employ mass spectrometry for protein identification

• Comprehensive validation matrix:

  • Test all antibodies across multiple validation methods

  • Document performance in different applications systematically

  • Create a validation score for each antibody based on cumulative performance

• Differential binding analysis:

  • Investigate if discrepancies correlate with experimental conditions

  • Test if lipid binding states affect antibody recognition

  • Determine if protein interaction partners mask epitopes

• Multi-laboratory validation:

  • Engage collaborative testing across different research groups

  • Implement standardized protocols to minimize technical variability

  • Pool data to identify consistent performers versus outliers

This systematic approach aligns with recommendations for high-throughput antibody validation platforms that enable unbiased discovery of antibody molecular signatures .

How can researchers apply enhanced validation techniques for ORP8/OSBPL8 antibodies in specialized experimental contexts?

Enhanced validation for specialized experiments requires tailored approaches:

• Dynamic phospholipid transport studies:

  • Validate antibody recognition of ORP8/OSBPL8 in different conformational states

  • Confirm antibody performance in lipid-rich environments

  • Verify epitope accessibility during transport cycle phases

• High-content imaging applications:

  • Validate signal-to-noise ratio across diverse cell types

  • Determine optimal fixation/permeabilization for epitope preservation

  • Establish quantitative validation metrics for automated image analysis

• Proximity-dependent labeling experiments:

  • Confirm antibody compatibility with BioID or APEX2 fusion proteins

  • Validate ability to detect physiologically relevant interaction partners

  • Establish controls for non-specific proximity labeling

• Single-cell analyses:

  • Validate detection sensitivity at low protein abundance

  • Assess batch effects across experimental replicates

  • Establish normalization methods for quantitative comparisons

Recent methodological advances in antibody screening technology, such as oPool+ display, offer promising approaches for high-throughput characterization of antibody specificity that could be applied to ORP8/OSBPL8 antibodies. This platform combines oligo pool synthesis with mRNA display to rapidly construct and characterize antibodies in parallel, enabling thousands of binding tests within days .